Abi-Jaoudeh, N., Valerin, J. B., Fernando, D., Lee, F., Choi, A., Imagawa, D., Glavis-Bloom, J., Jarmakani, M., Chan, K., Chen, K., Lai, Y., Yang, C., Chang, I. Y., Chung, C., Liu, C., Dayyani, F. (2026). A phase 2, open-label single-arm, multi-center study of trans-arterial tirapazamine embolization (TATE) combined with nivolumab (nivo) in patients with advanced immunotherapy-refractory hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.538